Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Paolo Ascierto and Maria Vitale.
Paolo Ascierto
Connection Strength
0.860
Maria Vitale
  1. Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis. J Transl Med. 2021 03 31; 19(1):132.
    View in: PubMed
    Score: 0.234
  2. May the analysis of 1918 influenza pandemic give hints to imagine the possible magnitude of Corona Virus Disease-2019 (COVID-19)? J Transl Med. 2020 12 22; 18(1):489.
    View in: PubMed
    Score: 0.230
  3. Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy. J Immunother Cancer. 2020 08; 8(2).
    View in: PubMed
    Score: 0.224
  4. SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study. J Immunother Cancer. 2021 02; 9(2).
    View in: PubMed
    Score: 0.058
  5. Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition. J Immunother Cancer. 2021 01; 9(1).
    View in: PubMed
    Score: 0.058
  6. Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists. J Immunother Cancer. 2020 10; 8(2).
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.